Switch to:
More From Other Websites
aTyr Pharma, Inc. Announces Closing of Initial Public Offering May 12 2015
aTyr Pharma Appoints Rare Disease Pioneer Mark Goldberg, M.D., to Board of Directors May 11 2015
aTyr Pharma, Inc. Announces Pricing of Initial Public Offering May 11 2015
aTyr Pharma Receives U.S. FDA Orphan Designation for ResolarisTM May 11 2015
Pisani: Markets shrug at big week of biotech IPOs May 07 2015
aTyr Pharma, Inc. Announces Pricing of Initial Public Offering May 06 2015
IPO Outlook: Down-Home Cookin', Fast-Casual Bojangles' Sizzles Investors May 05 2015


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK